Results 41 to 50 of about 6,021 (155)

NOTCH2NLC Repeat Expansions in Parkinsonian Disorders: Clinical and Neuroimaging Characteristics

open access: yesAnnals of Clinical and Translational Neurology, Volume 12, Issue 11, Page 2181-2192, November 2025.
ABSTRACT Objective Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder caused by NOTCH2NLC GGC repeat expansions, with heterogeneous clinical manifestations, including parkinsonism. Recent studies have identified NOTCH2NLC repeat expansions in patients with Parkinson's disease (PD) and atypical parkinsonism (aPM), suggesting ...
Han‐Lin Chiang   +7 more
wiley   +1 more source

Макуларна ретиношиза и нејзината семиотска важност [PDF]

open access: yes, 2015
Вовед. Поимот ретиношиза означува раздвојување во слоевите на неуроретината. Може да се случи во периферните делови на ретината, но исто така и во регионот на макула лутеа кога зборуваме за макуларна ретиношиза.
Blazevska, Karolina   +3 more
core  

Guillain–Barré Syndrome Following Malaria: A Rare Case Report From Rural Ethiopia and Literature Review

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Guillain–Barré syndrome (GBS) is an acute immune‐mediated polyradiculoneuropathy often triggered by infections. Malaria, a common parasitic disease in endemic regions, has rarely been associated with GBS. We report a case of a 21‐year‐old male from rural Ethiopia who developed GBS following Plasmodium vivax malaria.
Hayatu Awel Abdela   +2 more
wiley   +1 more source

Concentrações plasmáticas de citocinas em pacientes com lombalgia crônica por hérnia de disco: estudo transversal analítico [PDF]

open access: yes, 2010
CONTEXT AND OBJECTIVE: The role of immune response and proinflammatory cytokines in the pathogenesis of chronic pain has been of growing interest. In order to evaluate whether there is any association between disc herniation and elevated cytokine levels,
Bacellar, Olívia   +5 more
core   +1 more source

The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT North Sea‐Progressive Myoclonus Epilepsy (NS‐PME) is a progressive neurological disorder, initially only associated with the homozygous GOSR2 founder mutation (c.430G>T; p.Gly144Trp). Clinical symptoms include untreatable early‐onset ataxia, cortical myoclonus and epilepsy.
Sjoukje S. Polet   +4 more
wiley   +1 more source

Certain features of the cochleovestibular syndrome in the residual stage of traumatic brain disease [PDF]

open access: yes
Caloric and rotation tests were applied to the study of the vestibular analyser in 84 patients in the residual state of traumatic disease of the brain.
Garshin, M. I., Volyanskiy, V. Y.
core   +1 more source

Neonatal meningitis caused by streptococcus pneumonia in Iran [PDF]

open access: yes, 2015
Meningitis, pneumonia, and sepsis in newborns and young infants ...
Alaee, E.   +3 more
core  

Benign paroxysmal positional vertigo following whiplash injury: a myth or a reality? [PDF]

open access: yes, 2011
Objective: The aim of the study was to evaluate the true incidence, diagnosis, and treatment of benign paroxysmal positional vertigo (BPPV) arising after whiplash injury and to distinguish this type of posttraumatic vertigo from other types of ...
Croce,A   +4 more
core   +1 more source

Treatment of Single Patient With PMM2‐Congenital Disorder of Glycosylation With Govorestat (AT‐007), an Aldose Reductase Inhibitor

open access: yesJIMD Reports, Volume 66, Issue 6, November 2025.
ABSTRACT Aldose reductase inhibitors (ARI) have been identified as a potential treatment for phosphomannomutase‐2 congenital disorder of glycosylation (PMM2‐CDG), a serious condition for which no treatments are approved. We treated a single patient for 36 months 30 months of age at enrollment, under a single‐patient investigational new drug expanded ...
Elizabeth R. Jalazo   +4 more
wiley   +1 more source

Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review

open access: yesThe American Journal on Addictions, Volume 34, Issue 6, Page 589-602, November 2025.
Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy